Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002427459 | SCV001188942 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001451087 | SCV001654708 | likely benign | Neurofibromatosis, type 1 | 2024-10-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001451087 | SCV002561323 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003331025 | SCV004038283 | likely benign | not specified | 2023-08-07 | criteria provided, single submitter | clinical testing |